高榕创投
@gaorong
创造美好生活
Articles
Platonic Bio Closes Oversubscribed $55 Million Series A to Accelerate ADC Drug and Immuno-Oncology Platform Development
Enabling best-in-class and first-in-class ADCs to advance into clinical development.
Hygea Medical Completes Series C+ Round, Expanding Multi-Pipeline Portfolio in Minimally Invasive Tumor Interventional Therapy
Led by technologies such as the Cryoablation System, a new generation of minimally invasive tumor treatments is driving oncology toward procedures that are less invasive, more precise, and increasingly intelligent.
General AI Company Qiyuan World Completes 300 Million Yuan Series A Funding Round to Accelerate Buildout of AI Infrastructure for the Digital Age
Dedicated to creating great agent products, and bringing agents into every industry, every home, and every individual.
Guoxin Technology Secures New Round of Strategic Investment to Lead Innovation in IoT AI Chips
Covering the full-scenario application of "human-vehicle-home," shaping a better life with "chips."
Rongbao · June | BOSS Zhipin and Dingdong Maicai successfully go public; medical, industrial upgrade, and chip companies close new funding rounds
Xingji, Dongjing Yiwan, Qitan Technology, and other companies have completed new funding rounds.
Congratulations to Dingdong Maicai on its successful NYSE listing! | Gaorong Ventures News
Make fresh, quality ingredients as accessible as running water — within everyone's reach, for the benefit of all.
Packaging industry internet platform **Dongjing Yiwan** has completed a RMB 250 million Series B+ funding round, led by **Gaorong Ventures**.
Providing full-process, digital, and intelligent services for every link in the packaging industry chain.
Warm congratulations to BOSS Zhipin on its successful Nasdaq listing! | Gaorong Ventures News
China's largest online recruitment platform.
Zhuiyi Technology Secures New Strategic Funding Round to Deepen AI Capabilities and Accelerate Industrial Digital Transformation
Advance AI technology innovation and industrialization.
Qitan Tech Raises Over 400 Million Yuan in Series B, Leading the Nanopore Gene Sequencer Race
China's first fully self-developed nanopore gene sequencer is slated for mass production later this year.